Long-Term Disease Control of a Pancreatic Neuroendocrine Tumor with Lanreotide Autogel®: A Case Report

By  

Case Reports in Oncology, Vol. 7, Iss. 3, 2014-09 ,pp. : 673-680

Karger

Access to resources Recommend Favorite

The Use of Lanreotide Autogel® in the Treatment of Intestinal Obstruction in a Patient with Adenocarcinoma

By  

Case Reports in Oncology, Vol. 7, Iss. 1, 2014-01 ,pp. : 43-46

Karger

Access to resources Recommend Favorite

Slow-Release Lanreotide Treatment in Acromegaly: Effects on Quality of Life

By  

Psychotherapy and Psychosomatics, Vol. 68, Iss. 3, 1999-04 ,pp. : 165-167

Karger

Access to resources Recommend Favorite

Pseudomyxoma Peritonei: Symptom Control and Objective Radiological Response after Treatment with Lanreotide Autogel

By  

Case Reports in Oncology, Vol. 9, Iss. 1, 2016-01 ,pp. : 56-61

Karger

Access to resources Recommend Favorite

Cytotoxic chemotherapy for pancreatic neuroendocrine tumors

By  

JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, Vol. 22, Iss. 8, 2015-08 ,pp. : 628-633

John Wiley & Sons Inc

Access to resources Recommend Favorite